type here...

CATEGORIES

Press Release

LATEST

Editors Choice

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Medika Life -
Editors Choice

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

Medika Life -
Editors Choice

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Medika Life -
Editors Choice

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

Medika Life -
Editors Choice

GE HealthCare and Biofourmis Collaborate to Extend Patient Monitoring Outside the Hospital with Virtual Care-at-Home Solutions

Medika Life -
Injury

Sheba Medical Center Selects Two Digital Startups for Integration into Newly Expanded Rehabilitation Ward

Medika Life -
Health Insurance

Benchmark KFF Survey: Annual Family Premiums for Employer Coverage Rise 7% to Nearly $24,000 in 2023

Medika Life -
Editors Choice

KFF Survey Shows Complexity, Red Tape, Denials, Confusion Rivals Affordability as a Problem for Insured Consumers, With Some Saying It Caused Them to Go...

Medika Life -
Editors Choice

Clinics IV Life Launches a New Clinic Model to Change the Face of Charitable Maternal Care, Delivery to Impoverished Communities

Robert Turner, Founding Editor -
Press Release

The Journal – Artificial Intelligence in the Life Sciences – Highlights the Contributions of Women in Artificial Intelligence in the Life Sciences

Medika Life -
123...12Page 1 of 12

TRENDING

EDITORS CHOICE

New Data Shows No Evidence of COVID-19 Spread in Gyms

Medika Life -
Of More than 49.4 Million Health Club Visits, Only 0.0023 Percent Tested Positive for COVID-19

Hyper-Transmissible SARS-CoV-2 Variant Detected in U.S. Wastewater

Medika Life -
The SARS-CoV-2 B1.1.7 (UK Variant) test is available immediately both as a fee-for-service and as a complete, ready-to-use PCR kit for testing labs.

Texas Food Relief with NCS Group and #BStrong Initiative Deliver Food Aid Across Texas

Medika Life -
Each NCS Group Unlimited Carrier Fleet Vehicle brings a total of $180K+ worth of supplies and aid, and a total of six trucks are arriving in Texas

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories